Peer review reports
From: Overexpression of DDX49 in prostate cancer is associated with poor prognosis
Original Submission | ||
---|---|---|
1 Nov 2022 | Submitted | Original manuscript |
21 Nov 2022 | Reviewed | Reviewer Report - Naresh Kumar Saidha |
12 Dec 2022 | Reviewed | Reviewer Report |
29 Dec 2022 | Reviewed | Reviewer Report - Simone Morra |
20 Jan 2023 | Reviewed | Reviewer Report |
21 Feb 2023 | Author responded | Author comments - Jun Zhou |
Resubmission - Version 2 | ||
21 Feb 2023 | Submitted | Manuscript version 2 |
28 Feb 2023 | Author responded | Author comments - Jun Zhou |
Resubmission - Version 3 | ||
28 Feb 2023 | Submitted | Manuscript version 3 |
15 Apr 2023 | Reviewed | Reviewer Report |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
18 Apr 2023 | Editorially accepted | |
27 Apr 2023 | Article published | 10.1186/s12894-023-01251-4 |